美国移植和细胞治疗学会系列:#8-造血细胞移植受者非曲霉霉菌的管理和预防。

IF 3.6 3区 医学 Q2 HEMATOLOGY
Abby P. Douglas , Frederic Lamoth , Teny M. John , Andreas H. Groll , Terri Lynn Shigle , Genovefa A. Papanicolaou , Roy F. Chemaly , Paul A. Carpenter , Sanjeet S. Dadwal , Thomas J. Walsh , Dimitrios P. Kontoyiannis
{"title":"美国移植和细胞治疗学会系列:#8-造血细胞移植受者非曲霉霉菌的管理和预防。","authors":"Abby P. Douglas ,&nbsp;Frederic Lamoth ,&nbsp;Teny M. John ,&nbsp;Andreas H. Groll ,&nbsp;Terri Lynn Shigle ,&nbsp;Genovefa A. Papanicolaou ,&nbsp;Roy F. Chemaly ,&nbsp;Paul A. Carpenter ,&nbsp;Sanjeet S. Dadwal ,&nbsp;Thomas J. Walsh ,&nbsp;Dimitrios P. Kontoyiannis","doi":"10.1016/j.jtct.2025.01.892","DOIUrl":null,"url":null,"abstract":"<div><div>The Practice Guidelines Committee of the American Society of Transplantation and Cellular Therapy partnered with its Transplant Infectious Disease Special Interest Group to create a guideline focusing on non-<em>Aspergillus</em> invasive molds, which are uncommon yet lethal invasive fungal diseases in the peri-hematopoietic cell transplant (HCT) period. We used a compendium-style approach by dissecting this broad, heterogeneous, and highly complex topic into a series of standalone frequently asked questions (FAQs) and tables. Adult and pediatric infectious diseases and HCT content experts developed, then answered FAQs, and finalized topics with harmonized recommendations. All the evidence for non-<em>Aspergillus</em> invasive mold infection is non-RCT and mostly level III, therefore there are no recommendation grades, and instead key references are provided. Through this format, this “8th” topic in the series focuses on the relevant risk factors, diagnostic considerations, prophylaxis, and treatment approaches relevant to rare mold infections in the pre- and post-transplant periods.</div></div>","PeriodicalId":23283,"journal":{"name":"Transplantation and Cellular Therapy","volume":"31 4","pages":"Pages 194-223"},"PeriodicalIF":3.6000,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"American Society of Transplantation and Cellular Therapy Series: #8-Management and Prevention of Non-Aspergillus Molds in Hematopoietic Cell Transplantation Recipients\",\"authors\":\"Abby P. Douglas ,&nbsp;Frederic Lamoth ,&nbsp;Teny M. John ,&nbsp;Andreas H. Groll ,&nbsp;Terri Lynn Shigle ,&nbsp;Genovefa A. Papanicolaou ,&nbsp;Roy F. Chemaly ,&nbsp;Paul A. Carpenter ,&nbsp;Sanjeet S. Dadwal ,&nbsp;Thomas J. Walsh ,&nbsp;Dimitrios P. Kontoyiannis\",\"doi\":\"10.1016/j.jtct.2025.01.892\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The Practice Guidelines Committee of the American Society of Transplantation and Cellular Therapy partnered with its Transplant Infectious Disease Special Interest Group to create a guideline focusing on non-<em>Aspergillus</em> invasive molds, which are uncommon yet lethal invasive fungal diseases in the peri-hematopoietic cell transplant (HCT) period. We used a compendium-style approach by dissecting this broad, heterogeneous, and highly complex topic into a series of standalone frequently asked questions (FAQs) and tables. Adult and pediatric infectious diseases and HCT content experts developed, then answered FAQs, and finalized topics with harmonized recommendations. All the evidence for non-<em>Aspergillus</em> invasive mold infection is non-RCT and mostly level III, therefore there are no recommendation grades, and instead key references are provided. Through this format, this “8th” topic in the series focuses on the relevant risk factors, diagnostic considerations, prophylaxis, and treatment approaches relevant to rare mold infections in the pre- and post-transplant periods.</div></div>\",\"PeriodicalId\":23283,\"journal\":{\"name\":\"Transplantation and Cellular Therapy\",\"volume\":\"31 4\",\"pages\":\"Pages 194-223\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2025-02-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transplantation and Cellular Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S266663672501005X\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation and Cellular Therapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S266663672501005X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

美国移植和细胞治疗学会的实践指南委员会与其移植感染性疾病特别兴趣小组合作,制定了一项针对非曲霉菌侵袭性霉菌的指南,这是一种罕见但致命的侵袭性真菌疾病,发生在hct前后。我们使用概要式的方法,将这个广泛、异构且高度复杂的主题分解为一系列独立的常见问题(FAQs)和表格。成人和儿童传染病和HCT内容专家开发,然后回答常见问题,并最终确定主题与统一的建议。NAIMI的所有证据都是非rct的,而且大多是III级,因此没有推荐等级,而是提供了关键参考文献。通过这种形式,本系列的“第八”主题侧重于移植前后罕见霉菌感染的相关风险因素、诊断考虑、预防和治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
American Society of Transplantation and Cellular Therapy Series: #8-Management and Prevention of Non-Aspergillus Molds in Hematopoietic Cell Transplantation Recipients
The Practice Guidelines Committee of the American Society of Transplantation and Cellular Therapy partnered with its Transplant Infectious Disease Special Interest Group to create a guideline focusing on non-Aspergillus invasive molds, which are uncommon yet lethal invasive fungal diseases in the peri-hematopoietic cell transplant (HCT) period. We used a compendium-style approach by dissecting this broad, heterogeneous, and highly complex topic into a series of standalone frequently asked questions (FAQs) and tables. Adult and pediatric infectious diseases and HCT content experts developed, then answered FAQs, and finalized topics with harmonized recommendations. All the evidence for non-Aspergillus invasive mold infection is non-RCT and mostly level III, therefore there are no recommendation grades, and instead key references are provided. Through this format, this “8th” topic in the series focuses on the relevant risk factors, diagnostic considerations, prophylaxis, and treatment approaches relevant to rare mold infections in the pre- and post-transplant periods.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.00
自引率
15.60%
发文量
1061
审稿时长
51 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信